Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Exact Sciences Cor (NQ: EXAS )

44.27 -1.02 (-2.26%)
Streaming Delayed Price Updated: 1:27 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,722,860
Open 44.00
Bid (Size) 44.24 (1)
Ask (Size) 44.31 (2)
Prev. Close 45.30
Today's Range 43.67 - 45.15
52wk Range 40.62 - 98.89
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-approved blood test as a primary CRC screening option. Shield meets Medicare... 
Via Benzinga
Exposures Product Safety
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them. 
Via InvestorPlace

Performance

YTD
-39.98%
-39.98%
1 Month
+4.79%
+4.79%
3 Month
-24.68%
-24.68%
6 Month
-33.78%
-33.78%
1 Year
-54.61%
-54.61%

More News

Read More
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
Via Benzinga
This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street
Via The Motley Fool
Exact Sciences schedules second quarter 2024 earnings call
From Exact Sciences Corp.
Via Business Wire
Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts
Via Benzinga
How Is The Market Feeling About Exact Sciences?
Via Benzinga
The 3 Best Personalized Medicine Stocks to Buy in July 2024
Via InvestorPlace
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks
Via News Direct
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Via MarketBeat
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
Via InvestorPlace
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
Via The Motley Fool
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
Via Benzinga
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
Via Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Month
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Exact Sciences to Participate in June Investor Conferences
From Exact Sciences Corp.
Via Business Wire
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
Via InvestorPlace
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
Via Investor's Business Daily
Exposures Product Safety
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Earns 2024 Great Place To Work® Certification™
From Exact Sciences Corp.
Via Business Wire
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
From Exact Sciences Corp.
Via Business Wire
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.